|
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
The post MedCity Pivot …
more
Arundhati Parmar (via MedCity News)
|
5/23/25
|
|
Continue reading at Credihealth Blog »
more
Via Credihealth Blog
|
5/23/25
|
|
Continue reading at Credihealth Blog »
more
Via Credihealth Blog
|
5/23/25
|
|
Beam Therapeutics (NASDAQ: BEAM), a biotechnology firm pioneering precision genetic medicines via base editing, announced it will present updated data from its BEACON Phase 1/2 trial of BEAM-101 at …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
It’s obviously alarming to hear you’ve got a tumor in your brain. But if that tumor is a meningioma, the good news is that they’re almost always benign. “Meningiomas are slow-growing and …
more
Jessica Duque (via UNC Health Talk)
|
5/23/25
|
|
From Training to Trailblazing: Why Now Is the Time to Join AAPM as an Active Member You’ve spent years honing your skills, navigating complex cases, and shaping your identity in pain medicine. As …
more
Via American Academy of Pain Medicine
|
5/23/25
|
|
In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical and technology-driven company, are expanding their …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
Inaccurate provider data is creating a hidden crisis in healthcare by delaying care and driving up costs for both patients and health plans, according to CAQH CEO Sarah Ahmad. Her organization is …
more
Katie Adams (via MedCity News)
|
5/23/25
|
|
As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
As real-time inference overtakes training-centric approaches, a pivotal question emerges: how can the human element remain central in an increasingly autonomous ecosystem?
The post The Future of …
more
Darren Kimura (via MedCity News)
|
5/23/25
|
|
While prior authorization has made many headlines over the past year, concurrent review has not. Yet missteps in both processes leave hospitals in danger of not getting paid, which can result in …
more
Michelle Wyatt (via MedCity News)
|
5/23/25
|
|
Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported $58.2 million in net income for the fiscal year ended March 31, 2025, up 60% from the prior year, on revenue of $298.9 million, a 39% …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) has published its 2024 Sustainability and Climate Change Reports, detailing advances in ESG integration, climate risk management, and stakeholder …
more
InvestorBrandNetwork (IBN) (via Investor Brand Network)
|
5/23/25
|
|
Indian e-clinic startup CureBay also looks to expand its rural network.
more
Via MobiHealthNews
|
5/23/25
|
|
Continue reading at Credihealth Blog »
more
Via Credihealth Blog
|
5/23/25
|
|
Continue reading at Credihealth Blog »
more
Via Credihealth Blog
|
5/23/25
|
|
A GOP tax-and-spending bill the House approved Thursday would slash federal Medicaid reimbursement for states that offer health coverage to immigrants without legal status.
more
Phil Galewitz and Christine Mai-Duc (via California Healthline)
|
5/23/25
|
|
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and …
more
Stephanie Armour (via California Healthline)
|
5/23/25
|